Inhibitory effects of vasostatin-1 against atherogenesis

This study provided the first evidence that vasostatin-1 may serve as a novel therapeutic target for atherosclerosis.

Source: Clinical Science - November 6, 2018 Category: Biomedical Science Authors: Sato, Y., Watanabe, R., Uchiyama, N., Ozawa, N., Takahashi, Y., Shirai, R., Sato, K., Mori, Y., Matsuyama, T.-a., Ishibashi-Ueda, H., Hirano, T., Watanabe, T. Tags: PublishAheadOfPrint Source Type: research